Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00USF
|
|||
Former ID |
DAP000104
|
|||
Drug Name |
Trazodone
|
|||
Synonyms |
Beneficat; Desirel; Sideril; Tradozone; Trazalon; Trazodil; Trazodon; Trazodona; Trazodonum; Trazolan; Trazonil; Trialodine; Trittico; Desyrel Dividose; Trazodona [Spanish]; Trazodone Hcl; Trazodonum [Latin]; Beneficat (TN); Deprax (TN); Desirel (TN); Desyrel (TN); Desyrel(trazodone hcl salt); Molipaxin (TN); Thombran (TN); Trazodona [INN-Spanish]; Trazodone (Desyrel); Trazodone (INN); Trazodone [INN:BAN]; Trazodonum [INN-Latin]; Trazorel (TN); Trialodine (TN); Trittico (TN); 2-(3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl)[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one; 2-{3-[4-(3-chlorophenyl)piperazin-1-yl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one; 8-[3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl]-1,7,8-triazabicyclo[4.3.0]nona-2,4,6-trien-9-one hydrochloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Depression [ICD-11: 6A70-6A7Z; ICD-9: 311] | Approved | [1], [2] | |
Therapeutic Class |
Antidepressants
|
|||
Company |
Angelini research laboratories
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H22ClN5O
|
|||
Canonical SMILES |
C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
|
|||
InChI |
1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2
|
|||
InChIKey |
PHLBKPHSAVXXEF-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 19794-93-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
9365, 5659231, 7980825, 8153406, 11111900, 11111901, 11335371, 11360610, 11364318, 11366880, 11369442, 11372639, 11374249, 11377604, 11461582, 11466320, 11467440, 11484603, 11486179, 11488670, 11491375, 11492570, 11495238, 14828880, 24263015, 29224575, 46506648, 47216661, 47440129, 47515189, 47662138, 47736344, 47959598, 48184872, 48259097, 48259098, 49698420, 50057656, 50100361, 50104290, 56394831, 57322830, 75102958, 85209489, 85788818, 90341328, 92717483, 93619784, 96025310, 103188158
|
|||
ChEBI ID |
CHEBI:9654
|
|||
ADReCS Drug ID | BADD_D02266 ; BADD_D02267 | |||
SuperDrug ATC ID |
N06AX05
|
|||
SuperDrug CAS ID |
cas=019794935
|
Interaction between the Drug and Microbe | Top | |||
---|---|---|---|---|
The Abundace of Studied Microbe(s) Regulated by Drug | ||||
The Order in the Taxonomic Hierarchy of the following Microbe(s): Verrucomicrobiales | ||||
Studied Microbe: Akkermansia muciniphila
Show/Hide Hierarchy
|
[3] | |||
Hierarchy | ||||
Abundance Change | Decrease | |||
Experiment Method | High-throughput screening | |||
Description | The abundance of Akkermansia muciniphila was decreased by Trazodone hydrochloride (adjusted p-values: 2.77E-04). |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | 5-HT 1A receptor (HTR1A) | Target Info | Modulator | [4] |
Serotonin transporter (SERT) | Target Info | Modulator | [4] | |
KEGG Pathway | Serotonergic synapse | |||
cAMP signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | TCR Signaling Pathway | |||
Panther Pathway | 5HT1 type receptor mediated signaling pathway | |||
5HT2 type receptor mediated signaling pathway | ||||
5HT3 type receptor mediated signaling pathway | ||||
5HT4 type receptor mediated signaling pathway | ||||
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Reactome | Serotonin receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Monoamine Transport | |||
SIDS Susceptibility Pathways | ||||
NRF2 pathway | ||||
Synaptic Vesicle Pathway | ||||
Serotonin Transporter Activity | ||||
Serotonin HTR1 Group and FOS Pathway | ||||
Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 213). | |||
REF 2 | Emerging treatments for depression. Expert Opin Pharmacother. 2006 Dec;7(17):2323-39. | |||
REF 3 | Extensive impact of non-antibiotic drugs on human gut bacteria. Nature. 2018 Mar 29;555(7698):623-628. | |||
REF 4 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.